breast cancer

Mumbai-based pharma company unveils a decade-long innovation showing over 80 per cent effectiveness in targeting cancer cells with…

HS-20093: A breakthrough ADC poised to redefine second-line SCLC care in China, strengthening Jiangsu Hansoh's oncology leadership…

GlobalData reports the rise in HER2+ breast cancer cases, stressing the importance of cost-effective biosimilars as Zydus and…

The trial, known as CAPItello-290, was testing whether the drug combination improved overall survival in patients

Ongoing biomarker analysis may help clarify which patients could benefit most from alisertib Puma Biotechnology, announced the…

Launches Recovereez at the World Spice Congress

When breast cancer cells spread to other parts of the body it is called secondary or metastatic breast cancer and although…

A 440 mg vial of Trumab will be priced at Rs 15,749, which makes it the most affordable option available currently in the country

Docetaxcel Injections are indicated for breast cancer, non-small cell lung cancer, castration-resistant prostate cancer, gastric…

Olaparib is indicated primarily for certain forms of ovarian, breast, pancreatic and prostrate cancer